Dr. Jeffrey Gelblum, Senior Neurologist at First Choice Neurology educates patients about the risk of dementia and Alzheimer’s disease. Dr. Gelblum offers bi-weekly Lunch and Learn talks on Facebook LIVE …
Dr. Jeffrey Gelblum Talks about Proton Pump Inhibitors and Your Risk of Dementia Read More »
Biogen is providing its new Alzheimer’s drug Aduhelm free to some patients because of slow reviews by Medicare. There is a division among doctors about whether Aduhelm, also known as …
Biogen Offering Free Alzheimer’s Drug Aduhelm to Patients Read More »
First Choice Neurology is hosting a new series of Facebook Live events this month – COVID-19: Roadmap to Reopening. Jeffrey Gelblum, MD kicked off the series yesterday presenting “Re-engaging Older …
On Monday, April 20, Dr. Jeffrey Gelblum will present a Facebook Live event at 12:30 (Eastern Time) to talk about COVID-19 and blood tests that are antibody positive. Dr. Gelblum …
Am I Safe if My COVID-19 Blood Test is Antibody Positive? Read More »
Written by Jeffrey Gelblum, MD A “Virtual Neurology Office” is a fully functional neurology office accessible online via new Telehealth technology. The physicians of First Choice Neurology have pioneered the …
If you or a loved one are experiencing signs of early Alzheimer’s disease, there may soon be treatment and hope on the horizon. First Choice Neurology is participating in an …
BAN2401 Study to Assess New Alzheimer’s Treatment Read More »
First Choice Neurology is launching the HAPPIN Study (Hereditary Amyloid Polyneuropathy Prevalence in Idiopathic Neuropathy). It is the nation’s first research study of the prevalence of hereditary amyloid neuropathy. Doctors …
HAPPIN Study Seeks Patients with Idiopathic Neuropathy Read More »
What is Familial Amyloid Polyneuropathy? Familial Amyloid Polyneuropathy (FAP) is an inherited disease that causes progressive sensorimotor and autonomic nerve disorder. Peripheral nerve degeneration (polyneuropathy) begins in small fibers, resulting …
